Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group (Q35511099)
Jump to navigation
Jump to search
scientific article published on 9 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group |
scientific article published on 9 September 2011 |
Statements
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group (English)
Judith G Villablanca
Wendy B London
Arlene Naranjo
Patrick McGrady
Matthew M Ames
Joel M Reid
Renee M McGovern
Sarah A Buhrow
Hollie Jackson
Enno Stranzinger
Brenda J Kitchen
Paul M Sondel
Marguerite T Parisi
Gregory A Yanik
9 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference